Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients

BACKGROUND: Exenatide once weekly (QW) is a glucagon-like peptide-1 receptor agonist (GLP-1RA) for the treatment of type 2 diabetes. Safety and tolerability are key considerations in treatment selection. This analysis examines the safety and tolerability profile of exenatide QW, other approved GLP-1...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diabetes Metab Syndr Obes
Huvudupphovsmän: MacConell, Leigh, Gurney, Kate, Malloy, Jaret, Zhou, Ming, Kolterman, Orville
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2015
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4445788/
https://ncbi.nlm.nih.gov/pubmed/26056482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S77290
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk